Europe Angioplasty Balloons Market Size study, by Product Type (Normal Balloons, Cutting/Scoring Balloons, Drug Eluting Balloons), By Application (Coronary Angioplasty, Peripheral Angioplasty), By End User (Hospitals, Ambulatory Surgical Centers, Other En

Europe Angioplasty Balloons Market Size study, by Product Type (Normal Balloons, Cutting/Scoring Balloons, Drug Eluting Balloons), By Application (Coronary Angioplasty, Peripheral Angioplasty), By End User (Hospitals, Ambulatory Surgical Centers, Other End Users) and Country Forecasts 2022-2032

Europe Angioplasty Balloons Market is valued approximately at USD XX million in 2023 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2024-2032. Angioplasty balloons serve as medical instruments utilized during angioplasty interventions aimed at addressing obstructed or constricted blood vessels, especially within the heart and other bodily regions. A catheter featuring an affixed balloon is carefully introduced into the impacted artery, and upon reaching the blockage, the balloon is inflated. This action exerts pressure on the plaque or fatty build-ups, expanding the vessel and reinstating proper blood circulation. Such procedures effectively alleviate conditions such as coronary artery disease and peripheral arterial disease, ultimately enhancing cardiovascular well-being. This trend is supported by developments in imaging technologies that allow for more precise diagnosis and treatment planning, such as optical coherence tomography (OCT) and intravascular ultrasonography (IVUS). The rising shift towards personalized and precision medicine in cardiovascular care is a key trend for the Europe Angioplasty Balloons Market growth.

Europe has a rapidly aging population that is representing a significant rise in chronic conditions such as coronary artery disease (CAD), a prime target for angioplasty procedures with balloons. European countries boast well-established healthcare systems that prioritize high-quality patient care. Angioplasty balloons offer a minimally invasive approach compared to open-heart surgery, aligning with this focus. The European angioplasty balloons market experiences robust growth due to surge in the demand for angioplasty procedures and associated devices such as balloons, along with the continuous technological innovations in angioplasty balloon technologies, such as drug-eluting balloons and bioresorbable scaffolds, which enhance treatment efficacy and patient outcomes. Furthermore, the well-developed healthcare infrastructure across Europe and favorable regulatory environments and approvals for medical devices, facilitates the adoption and accessibility of angioplasty balloons. Moreover, growing awareness among healthcare professionals and patients about the benefits of minimally invasive procedures such as angioplasty, alongside lifestyle factors such as sedentary behavior and rising obesity rates, which, in turn, augmenting the growth of the Europe Angioplasty Balloons Market. However, high costs associated with the procedure, coupled with the complications associated with angioplasty procedures is expected to stifle Europe Angioplasty Balloons Market growth between 2022 and 2032.

The key countries considered for the Europe Angioplasty Balloons Market study includes UK, Germany, France, Italy, Spain, and Rest of Europe. In 2023, Germany is recorded with dominating position in the Angioplasty Balloons market with the highest number of market share because of substantial healthcare expenditure supports the advanced medical technologies, accelerates the growth of the angioplasty balloons market in the region. Germany is positioned for continued growth by focusing on high-quality, innovative angioplasty balloons, minimally invasive procedures, patient safety, and cost-effectiveness, the Angioplasty Balloons Market. The market in France, on the other hand, is expected to grow at the fastest rate over the forecast period.

Major market player included in this report are:
Braun Melsungen AG
Koninklijke Philips N.V.
BIOTRONIK
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10

The detailed segments and sub-segment of the market are explained below:

By Product Type
Normal Balloons
Cutting/Scoring Balloons
Drug Eluting Balloons

By Application
Coronary Angioplasty
Peripheral Angioplasty

By End User
Hospitals
Ambulatory Surgical Centers
Other End Users


By Region:
Europe
UK
Germany
France
Spain
Italy
ROE

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.





Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.